Regeneron Pharmaceuticals, Inc.

Baker Avenue Asset Management, LP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

383

Value ($000)

295

Weight

0.0%

2022 Q4 - 2025 Q4 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	295	0.0%	383	12/31/2025
2025 Q3	10/31/2025	477	0.0%	848	9/30/2025
2025 Q2	8/13/2025	325	0.0%	619	6/30/2025
2025 Q1	5/8/2025	410	0.0%	647	3/31/2025
2024 Q4	2/14/2025	463	0.0%	650	12/31/2024
2024 Q3	11/4/2024	707	0.0%	673	9/30/2024
2023 Q3	11/15/2023	36	0.0%	44	9/30/2023
2023 Q2	8/14/2023	31	0.0%	43	6/30/2023
2023 Q1	5/16/2023	646	0.0%	786	3/31/2023
2022 Q4	2/14/2023	491	0.0%	680	12/31/2022